Private equity sponsors love to move fast. Close the deal, restructure, extract value, exit. But the rush to sign often leaves a crater of tax liability that nobody spotted until it was too late.
I’ve seen deals where the tax due diligence was treated like a compliance checkbox. A spreadsheet of historical filings, a few Q&As with the seller’s accountant, maybe a letter from the target’s tax counsel. Then shock—halfway through the integration, you discover contingent liabilities, transfer pricing risks, or restructuring costs that should have been flagged.
The worst part: these aren’t edge cases. They’re predictable.
The standard approach falls short
Most PE firms commission a tax report during diligence. The Big Four come in, review the last three years of returns, check for audit history, maybe stress-test transfer pricing positions. It feels thorough. Usually it’s not.
Tax risk isn’t randomly distributed. You can’t spot it with checklists. The real exposure concentrates in specific areas—and those areas vary dramatically between sectors and deal types.
Consider a software services firm with a distributed workforce. A standard diligence report will flag the obvious risks: permanent establishment in underutilized countries, classification of contractors vs. employees in each jurisdiction. But what nobody asks is harder: how vulnerable are we to a restructuring that requires unwinding intercompany charges retroactively? That’s the kind of exposure that costs millions to resolve post-close.
Or take a roll-up strategy in professional services. The combine-and-consolidate approach looks clean on a spreadsheet. Until you realize the acquired firms are in different IP holding structures, three different countries are claiming R&D deductions on the same code, and the licensing arrangements predate the deal by years.
Where the gaps hide
I’d place the biggest risks in three areas:
Transfer pricing and intercompany transactions. The largest PE tax failures I’ve seen involve underestimated transfer pricing risk. A sponsor might consolidate operations, create an intercompany service company, or shift licensing income—all reasonable structurally. But if the commercial substance doesn’t match the pricing, you’re exposed. And tax authorities move slower than PE timelines. You restructure in Year 1, get audited in Year 3, and the bill arrives during hold period.
Contingent and deferred tax items. Most diligence looks at assessed taxes and provisioned liabilities. Fewer projects dig into deferred tax assets—especially in distressed acquisitions. A target with loss carryforwards looks attractive until you realize a change-of-control restriction kills half of them. Or you acquire a business with a NOL carryforward and structured like a partnership, only to discover the transferability is limited. The fair value drops by millions.
Integration and restructuring tax costs. Sponsors model EBITDA accretion from day one—consolidation costs, facility closures, systems merges. But restructuring carries embedded tax costs that often aren’t modeled separately. Layoffs in high-tax jurisdictions can trigger employment termination taxes. Closing facilities might trigger recapture of credits or hidden contingent payments. Consolidating entities can create withholding exposure.
A better framework
If you’re buying mid-market, your tax diligence needs to cover these areas:
Stress the jurisdictional exposure. Don’t just list where the target operates. Map revenue, profit, and assets to jurisdictions, then ask: which of these countries’ tax authorities would aggressively challenge our position? For each high-risk jurisdiction, model a conservative outcome. What happens if we lose that argument?
Test the intercompany terms. If the business has transfer pricing, have someone actually defend it from first principles. Can you document commercial substance? Do the margins make sense for the functions performed and risks borne? If you can’t defend it with confidence in 15 minutes, an auditor won’t either.
Quantify the integration tax bill. Work backward from your integration plan. For each major change—facility closure, consolidation, restructuring—flag the tax consequences. Model best-case, expected, and downside scenarios. Factor this into your EBITDA projections explicitly.
Check deferred tax assets, not just balances. Look at loss carryforwards, credits, and deductible temporary differences. For each one, read the underlying restriction. If it’s a partnership with a change-of-control, trace the language. If it’s a jurisdictional loss, check the carryforward period. One restriction can eliminate millions in value.
Pressure-test the seller’s positions. Ask the seller’s team to defend their tax positions in writing. Unclear sales tax treatment? Ask them to show you the analysis. Questionable R&D credits? Get the compliance file. This isn’t about accusing them of fraud—it’s about moving uncertainty to the surface before you buy it.
The reality
Clean diligence doesn’t mean perfect tax positions. It means you know which fights are worth winning and which to accept. It means you’ve modeled the downside. It means integration runs clean, without discovered tax bills.
Sponsors who move fast and win deals do so because they see risk clearly, not because they ignore it. Tax due diligence should be tight enough that your first integration doesn’t surface new exposures. That’s not bureaucracy—that’s insurance.
Your purchase price is already compressed. The last thing you want is to discover six months in that the real effective tax rate is three points higher than the model assumed.
Get in touch
If you’re running through a mid-market acquisition and want a second opinion on tax risk or integration planning, let’s talk. These are the kinds of details that separate clean deals from expensive surprises.
Reach out at mark@tanous.co.uk.